Ex-Raymond James exec sues, says he was fired after chemo

A former executive at Raymond James & Associates Inc. sued the company for $6 million, claiming he was fired after falling asleep as a result of chemotherapy.
JUN 08, 2010
A former executive at Raymond James & Associates Inc. sued the company for $6 million, claiming he was fired after falling asleep as a result of chemotherapy. Stephen Fredericks, who was a managing director of sales trading, filed the complaint today in New York state Supreme Court in Manhattan. Fredericks, who worked for Raymond James from 2002 to 2009, said he underwent chemotherapy in 2008 after being diagnosed with lymphoma. As a side effect, he occasionally “spontaneously fell asleep,” he said, and was told that if he nodded off, he couldn't continue to work. He went on disability in May 2009 and was terminated that July, according to the complaint. “If you fall asleep again, I'm going to have to get rid of you or you will have to go onto disability,” Fredericks claims his supervisor told him, according to the filing. Meanwhile, the complaint says, another sales trader with no medical disability fell asleep at the trading desk. “This sales trader also viewed pornography on his computer and he was not fired until after” Fredericks raised his claims, according to the complaint. Fredericks, who said his overall business grew from $3.5 million to $4 million in 2008 while working with his medical disability, claims he is owed back pay, unpaid commission and bonuses, benefits and interest in the amount of $3 million. He also is seeking $3 million in damages. Anthea Penrose, a spokeswoman for St. Petersburg, Florida- based Raymond James Financial Inc., declined to comment. The case is Stephen Fredericks v. Raymond James and Associates Inc., 107281-2010, New York state Supreme Court (Manhattan).

Latest News

Advisor moves: LPL recruitment momentum continues with $815M Northwestern Mutual team
Advisor moves: LPL recruitment momentum continues with $815M Northwestern Mutual team

Meanwhile, Raymond James and Tritonpoint Partners separately welcomed father-son teams, including a breakaway from UBS in Missouri.

SEC chief Atkins signals caution on prediction market ETFs amid broader rethink of novel fund structures
SEC chief Atkins signals caution on prediction market ETFs amid broader rethink of novel fund structures

Paul Atkins has asked staff to solicit public comment on novel ETFs, pausing the clock on as many as 24 filings linked to the booming event contracts market.

Private capital's $1 trillion bet on the American retirement account
Private capital's $1 trillion bet on the American retirement account

From 401(k)s to retail funds, Deloitte sees private equity and credit crossing into mainstream investing on two fronts at once.

Advisor moves: Wells Fargo Advisors pulls in $9.6b in fresh talent during first half of May
Advisor moves: Wells Fargo Advisors pulls in $9.6b in fresh talent during first half of May

Big-name defections from Morgan Stanley, UBS, and Merrill Lynch headline a busy two weeks of recruiting for the wirehouse.

Why uncertainty is making behavioral coaching more valuable than ever
Why uncertainty is making behavioral coaching more valuable than ever

Markets have always been unpredictable. What has changed is the amount of information investors are trying to process and the growing role advisors play in helping clients avoid emotional decisions

SPONSORED Are hedge funds the missing ingredient?

Wellington explores how multi strategy hedge funds may enhance diversification

SPONSORED Beyond wealth management: Why the future of advice is becoming more human

As technical expertise becomes increasingly commoditized, advisors who can integrate strategy, relationships, and specialized expertise into a cohesive client experience will define the next era of wealth management